Farida Hamied ?

I have done this site especially for Farida Hamied
in order to visit thishousewillexist.org

Sorry for my poor english translation.

-----



Mrs Farida is wife of Yusuf


Yusuf Khwaja Hamied is chairman of Cipla, a company founded by his father Khwaja Abdul Hamied.

Born in Vilnius, Lithuania, Yusuf Hamied was raised in Bombay. He is a Ph.D. in Chemistry from The University of Christ, Cambridge. He fought for big pharmaceutical companies to provide generic AIDS drugs to people in poor countries. He was awarded Padma Bhushan by Government of India in 2005. He is a student at Cathedral and John Connon School. He affectionately called by his Yuku Friends end. He is fond of Western classical music and was close friends since the days of youth with the conductor Zubin Mehta internationally-famous.

"Mr. Hamied comes by this mix of motivations - profit, social conscience and nationalism - by birthright. His father was a disciple of Mahatma Gandhi's brand of Indian nationalism whose family chipped in to send to study chemistry colonial master, England, India, in 1924. Instead, he changed boats and went to Germany, then the world leader in chemicals. Berlin on a lake, he met a Lithuanian Jewish socialist - The mother of Mr. Hamied. They fled Germany while shifting in Nazi hands, and chemical laboratories, pharmaceutical manufacturers and, later known as Cipla, was founded in 1935. "- Selling Cheap Drugs" generic ", copiers India thwart the industry, Donald G. McNeil Jr., New York Times, 1 December 2000

Hamied has led efforts to eliminate AIDS in the developing world and to give medicines to patients regardless of their creditworthiness rescue.

---> Site for Farida Hamied

Treatments Discount
Cipla, an Indian pharmaceutical company has proposed to the French NGO Medecins Sans Frontieres (Nobel Peace Prize 1999) triple therapy against AIDS at a price of $ 350 per year per patient instead of 10 000 charged in Europe or the States USA.

Only a few days after the earthquake in India that the pharmaceutical company Cipla has decided to propose to the French non-governmental organization, Doctors Without Borders, at least triple the price against the AIDS virus. The pharmaceutical company that manufactures generic drugs, MSF provides treatment therefore $ 350 per year per patient instead of 10 000 dollars practiced today in Europe or the United States. The chairman of Cipla, Yusuf Hamied has even expressed its willingness to engage in MSF "10 000 20 000 or 30 000 doses, much as they want." The lab also offers to sell the same product directly to the governments but for $ 600

-> It's created for Farida Hamied

"If we do not realize the extent of the disease, AIDS will be a bigger holocaust in India than the earthquake," said Dr. Yusuf Hamied. Indeed, the projections made for India include 50 million patients with HIV by 2005. This offer, however, should significantly contribute to open access to third world countries for the fight against HIV. Currently, Senegal payroll between 1000 and 1821 dollars per year the price of triple therapy.

MSF forty projects to fight against AIDS worldwide, including twenty in Africa. But for now, only five have triple therapies.

Down prices even further

"This offer is good news because it means that the price of medicine down" said Kevin Moody, a spokesman for MSF in Amsterdam. However, it is however not the intention nor the means to MSF acts as an intermediary between the laboratory and the Indian government: "We will not act as intermediate distributor, we do not means. But we buy for our own projects "held to clarify Kevin Moody. Indeed, the goal for several years of Doctors without Borders, is to lower the price of triple therapy at $ 200 per year per patient. A goal within reach if we are to judge by this offer that demonstrates that major global pharmaceutical companies can still lower their prices.

Last May, shortly before the conference in Durban, South Africa, several major pharmaceutical companies worldwide, including Switzerland, Roche, American Merck or Bristol Myers Squibb and Glaxo Wellcome of Britain, had made an announcement effect by providing countries developing treatments for less. But the tariffs have been very on top of those we expected.

MSF must now establish a strategy and respond to the offer of Cipla February 15 next in Paris.

----> Site for Farida Hamied

A pharmaceutical giant dismissed

September 4, 2009 - The news has not made much noise in the media: The Delhi High Court dismissed the complaint last August 18 Bayer against the Indian government and the generic drug manufacturer Cipla, Bombay. The court presided over by Ravinfra Bhat has even imposed on the pharmaceutical giant "costs for unjustified use of legal channels," adding that the generic "preparations are not undesirable."

The complaint filed last year by Bayer intended to authorize the Office Cipla produce the active ingredient sorafenib, protected by a patent, in order to prevent the approval of a generic cancer drug.

-> It's created for Farida Hamied

The decision of the High Court of New Delhi is an act of courage and independence, reaffirming that the drugs manufactured in India are critical to patients worldwide. This is a victory for public health against those who want to enslave the private ownership of patents, the exclusive benefit of the monopolies of the pharmaceutical industry.

Cipla is the laboratory which launched in 1994, the first generic AZT, putting the triple to $ 1 a day for many patients. However, many obstacles remained to rise and, according to a WHO study, nearly three-quarters of AIDS drugs are still under monopoly in 2006 and 77% of Africans still lacked access to antiretroviral treatment ( ARVs), five years after the Doha agreements.

In the Philippines, Indonesia, Niger, Botswana and Haiti, there was no generic available when the World Health Organization has sounded the alarm, even in these countries Where there shall ARV molecules.

The Doha Declaration (2001) recognized the States yet WTO members' right to grant compulsory licenses and the freedom to determine the grounds upon which such licenses are granted. " In reality the use of these licenses is still very rare, "because of political pressure from the Bush administration" has come to denounce Dr. Pedro Chequer, Brazil's National Programme to Fight against AIDS.

Cipla laboratories have built their reputation on a global simple slogan: "no to medical apartheid." Quoting a Jewish proverb that says "if you can save a life, you save the world", the CEO of Cipla, Yusuf Hamied extended action of his father - the founder of the firm in 1935 - starting "at war against one of the largest global injustices. "

Last May, the laboratories have reported on a project in Mexico to provide a generic Tamiflu, Oseltamivir Cipla, "as effective as the original product of Roche," said WHO.

India is the fourth largest drug producer in the world, it exports worth $ 6.5 billion. Cipla is the 3rd largest pharmaceutical group in the country.

-> Site for Farida Hamied